Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: Phase II Study of Blinatumomab in Patients With B-cell Lineage Acute Lymphocytic Leukemia With Positive Minimal Residual Disease
Brief Summary: The goal of this clinical research study is to learn if Blinacyto (blinatumomab) can help to control ALL with positive MRD. The safety of this drug will also be studied.